Duke logo

UM1 10005 Atezolizumab (Sarcoma) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to test any good and bad effects of the study drug called atezolizumab.

What is the Condition Being Studied?

Advanced alveolar soft part sarcoma

Who Can Participate in the Study?

Adults with advanced alveolar soft part sarcoma that is not curable by surgery and for which there is no standard treatment.

Age Group
Adults

What is Involved?

If you join this study you will:
-- Be given the study drug Atezolizumab by vein into your arm. This will take about 1 hour
-- Need to stay in the hospital for 2-3 hours after the first time you get the drug
--This drug is given in cycles; each cycle involves one dose of study drug every 21 days (on same day of each cycle) until you experience unacceptable side effects or your tumor grows

Study Details

Full Title
A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma
Principal Investigator
Medical Oncologist
Protocol Number
IRB:PRO00082954
NCT:NCT03141684
Phase
Phase II
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698